DAPK1 and nonpapillary renal cell carcinoma: In clear-cell renal cell carcinoma (ccRCC), sunitinib-resistant ccRCC cells showed considerably lower death-associated protein kinase 1 (DAPK1) mRNA and protein levels than sunitinib-sensitive ccRCC cells.